CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) EBIT Margin (2018 - 2022)

Updated

CytoDyn (CYDY) reported EBIT Margin of -232494.12% for fiscal Q4 2022 (quarter ended May 31, 2022).

Analysis

CytoDyn (CYDY) EBIT Margin (2018 - 2022) Analysis & Trends

For FY2022 (ended May 31, 2022), CytoDyn posted EBIT Margin of -48468.00%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 -232,494.12%
Nov 30, 2021 -11,254.22%
Aug 31, 2021 -52,773.17%
Nov 30, 2019 -2,192.70%
Aug 31, 2019 -2,052.40%
Nov 30, 2018 -10,923.35%
Aug 31, 2018 -12,891.80%
API Access

CytoDyn EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEY